Healthcare provider profile · identity verified

Lijo K Thomas, MD

Internal Medicine · AUBURN, WA · NPI 1821169905

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	512	143
Amlodipine Besylate	Amlodipine Besylate	420	112
Levothyroxine Sodium	Levothyroxine Sodium	346	89
Losartan Potassium	Losartan Potassium	295	85
Gabapentin	Gabapentin	284	74
Lisinopril	Lisinopril	256	77
Metoprolol Succinate	Metoprolol Succinate	240	68
Omeprazole	Omeprazole	224	64
Alendronate Sodium	Alendronate Sodium	208	59
Hydrochlorothiazide	Hydrochlorothiazide	186	59
Simvastatin	Simvastatin	176	53
Trazodone Hcl	Trazodone Hcl	153	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	148	29
Rosuvastatin Calcium	Rosuvastatin Calcium	148	50
Metformin Hcl	Metformin Hcl	137	38
Albuterol Sulfate Hfa	Albuterol Sulfate	126	49
Furosemide	Furosemide	122	36
Sertraline Hcl	Sertraline Hcl	101	26
Alprazolam	Alprazolam	97	21
Pantoprazole Sodium	Pantoprazole Sodium	97	27
Tramadol Hcl	Tramadol Hcl	97	20
Venlafaxine Hcl Er	Venlafaxine Hcl	88	21
Potassium Chloride	Potassium Chloride	87	27
Citalopram Hbr	Citalopram Hydrobromide	85	23
Tamsulosin Hcl	Tamsulosin Hcl	79	17
Atenolol	Atenolol	74	20
Metformin Hcl Er	Metformin Hcl	74	26
Buspirone Hcl	Buspirone Hcl	73	19
Pravastatin Sodium	Pravastatin Sodium	73	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	suppressed
Eliquis	Apixaban	69	12
Hydralazine Hcl	Hydralazine Hcl	65	22
Carvedilol	Carvedilol	63	20
Repaglinide	Repaglinide	55	14
Fluoxetine Hcl	Fluoxetine Hcl	53	15
Tizanidine Hcl	Tizanidine Hcl	53	23
Montelukast Sodium	Montelukast Sodium	51	16
Spironolactone	Spironolactone	51	13
Famotidine	Famotidine	50	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	13
Metoprolol Tartrate	Metoprolol Tartrate	48	14
Olmesartan Medoxomil	Olmesartan Medoxomil	48	14
Duloxetine Hcl	Duloxetine Hcl	47	15
Xarelto	Rivaroxaban	47	12
Allopurinol	Allopurinol	46	13
Estradiol	Estradiol	46	16
Glipizide	Glipizide	46	17
Fluticasone Propionate	Fluticasone Propionate	44	19
Oxycodone Hcl	Oxycodone Hcl	43	12
Paroxetine Hcl	Paroxetine Hcl	43	12
Ezetimibe	Ezetimibe	40	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	12
Mirtazapine	Mirtazapine	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Jardiance	Empagliflozin	33	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	11
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Meloxicam	Meloxicam	29	11
Clonazepam	Clonazepam	28	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Irbesartan	Irbesartan	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Ozempic	Semaglutide	23	suppressed
Valsartan	Valsartan	23	suppressed
Lorazepam	Lorazepam	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	11
Myrbetriq	Mirabegron	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Carbamazepine Er	Carbamazepine	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Cimetidine	Cimetidine	15	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Prednisone	Prednisone	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Diazepam	Diazepam	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Aripiprazole	Aripiprazole	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Zenpep	Lipase/Protease/Amylase	12	suppressed
Baclofen	Baclofen	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error